Recently, a three-phased (discovery, verification and validation) proteomic analyses by Basak et al. (24) have discovered that the down-regulation of apolipoproteins and albumin might be responsible for the impairment of the reverse cholesterol pathway during atherosclerosis in coronary artery disease (CAD) patients. Here, ALB is linked to coronary artery disorder.